Studying polymorphic variants of the NAT2 gene (NAT2*5 and NAT2*7) in Nenets populations of Northern Siberia

被引:8
|
作者
Tiis, Roza Pavlovna [1 ,2 ]
Osipova, Ludmila Pavlovna [1 ,2 ]
Lichman, Daria Veniaminovna [1 ,2 ]
Voronina, Elena Nikolaevna [2 ,3 ]
Filipenko, Maxim Leonidovich [2 ,3 ]
机构
[1] RAS, Inst Cytol & Genet, SB, Novosibirsk 630090, Russia
[2] Novosibirsk State Univ, Novosibirsk 630090, Russia
[3] RAS, Inst Chem Biol & Fundamental Med, SB, Novosibirsk, Russia
基金
俄罗斯科学基金会;
关键词
Xenobiotics; NAT2; gene; NAT2*5; rs1801280; NAT2*7; rs1799931; Forest and Tundra Nenets; Northern Siberia; ARYLAMINE N-ACETYLTRANSFERASES; DRUG-METABOLIZING-ENZYMES; LUNG-CANCER; BLADDER-CANCER; RISK; N-ACETYLTRANSFERASE-2; GSTM1; SUSCEPTIBILITY; ACETYLATION; GENOTYPE;
D O I
10.1186/s12863-020-00909-4
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background N-acetyltransferase 2 plays a crucial role in the metabolism of a wide range of xenobiotics, including many drugs, carcinogens, and other chemicals in the human environment. The article presents for the first time data on the frequency of two important "slow" variants of NAT2 gene (NAT2*5, rs1801280 and NAT2*7, rs1799931), which significantly affect the rate of xenobiotics acetylation, among representatives of indigenous populations of Forest and Tundra Nenets in Northern Siberia. The aim of this study was to identify the frequencies of these variants and compare them with frequencies in other ethnic populations. Results NAT2*5 (T341C) genotyping revealed frequencies of 28,0% and 38,6% for Tundra and Forest Nenets, respectively. The frequencies of NAT2*7 (G857A) variant were 9,8% and 8,2% for Tundra and Forest Nenets, respectively. Polymorphic variants frequencies for Nenets are intermediate between those in populations of Europeans and Asians. These results can probably be explained by the presence of both European and Asian components in Nenets gene pools. Conclusions The results of this study expand the knowledge of NAT2 polymorphism in world populations. These data may also help assess the genetic predisposition of Nenets to multifactorial diseases associated with polymorphism in the NAT2 gene and, in general, contribute to the development of personalized medicine in reference to native people of Siberia.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] NAT2 gene diversity and its evolutionary trajectory in the Americas
    Bisso-Machado, R.
    Ramallo, V.
    Paixao-Cortes, V. R.
    Acuna-Alonzo, V.
    Demarchi, D. A.
    Sandoval, J. R. S.
    Granara, A. A. S.
    Salzano, F. M.
    Hunemeier, T.
    Bortolini, M. C.
    PHARMACOGENOMICS JOURNAL, 2016, 16 (06): : 559 - 565
  • [42] NAT2 gene diversity and its evolutionary trajectory in the Americas
    R Bisso-Machado
    V Ramallo
    V R Paixão-Côrtes
    V Acuña-Alonzo
    D A Demarchi
    J R S Sandoval
    A A S Granara
    F M Salzano
    T Hünemeier
    M C Bortolini
    The Pharmacogenomics Journal, 2016, 16 : 559 - 565
  • [43] NAT2 Gene Polymorphisms in Turkish Patients with Psoriasis Vulgaris
    Dursun, Recep
    Dursun, Hatice Gul
    Zamani, Ayse Gul
    Yildirim, Mahmut Selman
    Cinar, Elknur
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [44] Drug-induced hepatotoxicity and association with slow acetylation variants NAT2*5 and NAT2*6 in Cameroonian patients with tuberculosis and HIV co-infection
    Cho, Frederick Nchang
    Achidi, Eric A.
    Enoh, Jude Eteneneng
    Pallerla, Srinivas Reddy
    Linh, Le Thi Kieu
    Tong, Hoang Van
    Kamgno, Joseph
    Penlap, Veronique Beng
    Adegnika, Ayola Akim
    Lekana-Douki, Jean-Bernard
    Bouyou-Akotet, Marielle Karine
    Kahunu, Gauthier Mesia
    Lutete, Gaston Tona
    Bates, Mathew
    Tembo, John
    Elton, Linzy
    McHugh, Timothy D.
    Grobusch, Martin P.
    Zumla, Alimuddin
    Ntoumi, Francine
    Velavan, Thirumalaisamy P.
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [45] THE RISK OF SPORADIC RECTAL CANCER IN PATIENTS WITH NAT2*5A-C481T, NAT2*6B-G590A, NAT2*18-A845C, NAT2*7B-G857A RAPID ACETYLATOR PHENOTYPE. CORRELATION WITH HIGH FRIED MEAT INTAKE AND SMOKING STATUS
    Procopciuc, L.
    Osian, G.
    Olteanu, I
    Vlad, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 60 - 60
  • [46] Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms
    Hein, DW
    Doll, MA
    Fretland, AJ
    Leff, MA
    Webb, SJ
    Xiao, GH
    Devanoboyina, US
    Nangju, NA
    Feng, Y
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2000, 9 (01) : 29 - 42
  • [47] Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations
    Delomenie, C
    Sica, L
    Grant, DM
    Krishnamoorthy, R
    Dupret, JM
    PHARMACOGENETICS, 1996, 6 (02): : 177 - 185
  • [48] Haplotype-specific PCR for NAT2 diplotyping
    Nuanjun Wichukchinda
    Jirapa Pakdee
    Punna Kunhapan
    Wimala Imunchot
    Licht Toyo-oka
    Katsushi Tokunaga
    Surakameth Mahasirimongkol
    Human Genome Variation, 7
  • [49] NAT2 variation and idiopathic talipes equinovarus (clubfoot)
    Hecht, Jacqueline T.
    Ester, Audrey
    Scott, Allison
    Wise, Carol A.
    Iovannisci, David M.
    Lammer, Edward J.
    Langlois, Peter H.
    Blanton, Susan H.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2007, 143A (19) : 2285 - 2291
  • [50] Analysis of NAT and CYP1A2 phenotypes and NAT2* genotype by capillary electrophoresis
    Meacher, DM
    Rasmussen, RE
    Menzel, DB
    BIOMARKERS, 1998, 3 (03) : 205 - 218